776 The anti-tumor activity of HER-2/neu ICD therapeutic cancer vaccine (AST-301, pNGVL3-hICD) in Her2-expressed gastric cancer xenograft model
Main Authors: | Gyeong Seok Jo, Eunkyo Joung, Jung Hyu Shin, Hye Lim Lee, Jinback Lim, Yoonyi Kim, Hyo-Hyun Park, Hunwoo Shin, Hun Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1414 Antitumor effect of HER2-hICD vaccine combining with HER2 ADC depending on T cell existence in a mouse model: pooled analysis
by: Hye-Ran Kim, et al.
Published: (2023-11-01) -
897 AST-301, a pDNA-based cancer vaccine encoding HER2-ICD, enhances anti-tumor effect of HER2-ADC in a HER2-expressed gastric cancer xenograft model
by: Eunkyo Joung, et al.
Published: (2023-11-01) -
860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model
by: Kyong Hwa Park, et al.
Published: (2021-11-01) -
HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01) -
Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017-02-01)